Welcome to our dedicated page for Fmc news (Ticker: FMC), a resource for investors and traders seeking the latest updates and insights on Fmc stock.
FMC Corporation (NYSE: FMC) is a global agricultural sciences company focused on crop protection solutions, including biologicals, crop nutrition, and digital and precision agriculture. The FMC news feed on Stock Titan aggregates company-issued press releases and other coverage so readers can follow how this agricultural chemical manufacturer communicates its strategy, performance and product developments over time.
FMC regularly publishes earnings announcements and financial updates, including quarterly results, adjusted EBITDA and adjusted earnings per share metrics, along with commentary on regional performance in North America, Latin America, Asia and EMEA. The company also announces the timing of upcoming earnings releases and webcast conference calls, providing details for internet broadcasts and telephone access, as well as replay information.
Investors can track dividend declarations and changes to the dividend policy through FMC’s news releases, which have included both regular quarterly dividend announcements and a reduction in the quarterly dividend as part of a broader emphasis on debt reduction. The news flow also covers strategic and operational updates, such as the intention to divest the India commercial business, restructuring and cost actions, and initiatives like Project Foundation that are designed to reshape the manufacturing footprint and cost structure.
Product- and technology-related news is another key element of FMC’s disclosures. The company has reported regulatory registrations for products such as Fundatis herbicide powered by Isoflex active in Great Britain, and has highlighted the role of new active ingredients and biologicals in its growth portfolio and Plant Health business. Updates on registrations, launches and regional commercialization provide insight into FMC’s pipeline and portfolio evolution.
FMC’s news also includes leadership and governance updates, such as changes in executive roles and Board composition, and announcements that senior executives will speak at investor conferences hosted by firms like Goldman Sachs and Jefferies. For investors, analysts and others following the agricultural sciences sector, the FMC news page offers a centralized view of how the company reports its financial performance, portfolio developments and corporate actions.
FMC (NYSE: FMC) will release first quarter 2026 earnings on Wednesday, April 29, 2026 after market close and will host a public webcast conference call on Thursday, April 30, 2026 at 9:00 a.m. ET.
According to the company, the release will be posted on its investor website and a live webcast and dial-in details are provided for investors and analysts.
FMC Corporation (NYSE: FMC) announced that Chairman and CEO Pierre Brondeau and EVP & CFO Andrew Sandifer will speak at the J.P. Morgan Industrials Conference on March 18, 2026 at 10:05 a.m. ET. A live webcast will be available at www.fmc.com/investors.
FMC (NYSE: FMC) declared a regular quarterly dividend of $0.08 per share, payable on April 16, 2026 to shareholders of record at the close of business on March 31, 2026.
This distribution signals a current cash return to shareholders via the company's quarterly dividend program.
FMC (NYSE: FMC) announced the election of Michael F. Barry to its Board of Directors, effective February 27, 2026. He will join the Audit and Compensation and Human Capital committees and brings 30+ years in specialty chemicals and prior CEO and chairman experience.
Barry led Quaker Houghton through major growth, including revenue expansion from $451 million in 2009 to $1.8 billion in 2021 and 27 strategic acquisitions, and will advise on FMC's 2026 strategic priorities.
FMC (NYSE: FMC) announced that HRAC has classified rimisoxafen as the industry's first dual mode of action herbicide, designated under HRAC Groups 12 and 32. The classification recognizes dual inhibition of PDS and SDPS, increasing the barrier to weed resistance.
Rimisoxafen targets palmer amaranth and waterhemp, is intended for broadacre crops, was discovered at FMC's Stine Research Center, and regulatory dossiers will begin in 2026.
FMC (NYSE: FMC) said CEO Pierre Brondeau and CFO Andrew Sandifer will speak at the Bank of America Global Agriculture and Materials Conference on February 25, 2026 at 2:45 p.m. ET. A live webcast will be available at www.fmc.com/investors.
FMC (NYSE:FMC) announced the Board has authorized exploration of strategic options, including a potential sale, while outlining 2026 priorities to strengthen the balance sheet and commercialize new active ingredients.
2026 guidance: $3.60–$3.80B revenue, $670–$730M Adjusted EBITDA, $1.63–$1.89 Adjusted EPS; company plans to pay down $1B debt via asset sales/licensing.
FMC (NYSE: FMC) announced its 2026 Annual Meeting of Stockholders will be held via live webcast on Tuesday, April 28, 2026 at 2:00 p.m. ET. The board set the record date as close of business Friday, February 27, 2026 to determine stockholders entitled to notice and voting rights. Additional details will be provided in the proxy statement and proxy materials. Instructions to access the webcast will be available on the company's Investor Relations website at https://investors.fmc.com.
FMC (NYSE: FMC) will release fourth quarter 2025 earnings on Wednesday, February 4, 2026 after market close via PR Newswire and the company's investor website.
The company will host a public webcast conference call on Thursday, February 5, 2026 at 9:00 a.m. ET. Webcast and telephone access details, including U.S. local and toll-free numbers, global dial‑ins, an access code, and a pre‑registration link, are available on the investor site.
A replay will be available online and by telephone from 11:00 a.m. ET on February 5, 2026 until February 12, 2026.
FMC (NYSE: FMC) announced a regular quarterly cash dividend of $0.08 per share. The dividend is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This is a routine cash distribution to eligible shareholders.